# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123282
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:35
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | gern-20240930.htm iXBRL | 10-Q | 2620693
2 | EX-10.1 | gern-ex10_1.htm | EX-10.1 | 114556
3 | EX-31.1 | gern-ex31_1.htm | EX-31.1 | 15875
4 | EX-31.2 | gern-ex31_2.htm | EX-31.2 | 15904
5 | EX-32.1 | gern-ex32_1.htm | EX-32.1 | 8529
6 | EX-32.2 | gern-ex32_2.htm | EX-32.2 | 8385
| Complete submission text file | 0000950170-24-123282.txt |  | 9343858

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | gern-20240930.xsd | EX-101.SCH | 1165388
61 | EXTRACTED XBRL INSTANCE DOCUMENT | gern-20240930_htm.xml | XML | 1674776

Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 241435523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)